EPAS1 and neoplasm: Targeting of HIF-2α with the small inhibitor TC-S7009 inhibited tumor growth in two different CS xenograft models obtained after orthotopic or subcutaneous injection of the SW1353 and JJ012 CS cell lines, respectively.